Plain-English translation of NCT06502834 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing whether D. piger, a live bacterial treatment taken by mouth, is safe and affects how your body processes alcohol and handles blood sugar. You would take either the medication or a placebo (inactive) version daily for one month, while researchers monitor your safety and measure changes in your liver and metabolism.
Overweight people often develop problems with how their bodies handle sugar and develop fatty liver disease. Researchers believe this medication might help improve these metabolic problems, so they're testing whether it's safe and whether it actually works.
You would visit the clinic weekly for four weeks to check on your safety and health. At the start and end of the study, you'd have some medical tests done, including an imaging scan of your liver, an ultrasound-like test to check liver stiffness, and a stomach camera procedure. Between visits, you would take either the study medication or placebo as a liquid suspension once daily at home.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Netherlands